ClearPoint Neuro (CLPT) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Viemed Healthcare (VMD) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 36.4% versus a loss of 59.6%. Over five years, VMD leads with a +62.4% price change compared with -40.6% for CLPT. Viemed Healthcare is the larger company by market cap ($356.9 million vs $325.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLPT | VMD |
|---|---|---|
| Share price | $10.66 | $9.37 |
| Market cap | $325.18M | $356.89M |
| 1-day change | -3.18% | +0.43% |
| YTD return | -22.08% | +26.11% |
| 1-year return | -59.61% | +36.39% |
| 5-year return | -40.65% | +62.39% |
| P/E ratio (TTM) | — | 26.03 |
| Forward P/E | — | 23.43 |
| EPS (TTM) | $-1.18 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.10 | $12.61 |
| 52-week low | $8.27 | $6.05 |
| Distance from 52-week high | -64.58% | -25.69% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +120.45% | +33.40% |
| Average volume | 639.50K | 354.17K |
| Shares outstanding | 30.50M | 38.09M |
| Employees | 160 | 1,438 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VMD has outperformed CLPT by 96.0 percentage points over the past year.
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 160 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
CLPT vs VMD FAQ
Which is bigger, ClearPoint Neuro or Viemed Healthcare?
Viemed Healthcare (VMD) is larger, with a market capitalization of $356.89M compared with $325.18M for ClearPoint Neuro (CLPT).
Which stock has performed better over the past year, CLPT or VMD?
VMD returned +36.39% over the past 12 months, compared with -59.61% for CLPT (price return, excluding dividends). Past performance does not predict future results.
Are ClearPoint Neuro and Viemed Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for ClearPoint Neuro and Misc Health and Biotechnology Services for Viemed Healthcare.